Cathie Wood's ARK Innovation Stocks Performance Guide: Pacific Biosciences of Calif (PACB)
PACB has no dividends
Table and Chart of PACB Performance
See what a $1,000 investment in PACB is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| PACB Returns | |
|---|---|
| Start Date | Nov-29-2013 |
| Start Price | $4.22 |
| End Date | Nov-28-2023 |
| End Price | $8.63 |
| # Prices | 121 |
| Min Date | Mar-29-2018 |
| Min Price | $2.05 |
| Max Date | Jun-30-2021 |
| Max Price | $34.97 |
| Total Return | 104.50% |
| Annualized Return | 7.35% |
| Current Value of $1,000 Purchase | $2,045 |
| Number Returns | 7,260 |
| Average Return | 96.56% |
| Number Profitable Returns | 4,400 |
| Percent Profitable Returns | 60.61% |
| Number Unprofitable Returns | 2,860 |
| Percent Unprofitable Returns | 39.39% |
| Profitable to Unprofitable Returns Ratio | 1.54 |
| PACB Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,257,227,000 | Price to Sales | 14.96 |
| Earnings per Share | $-1.2700 |
| PE Ratio | None |
| PE to Growth Ratio | -0.17 |
| Price to Book | 3.403 |
| PRICE DATA | |
| 52 Week High | $14.55 |
| 52 Week Low | $5.74 |
| Analyst Target Price | $12.62 |
| 50-Day Moving Average | $7.83 |
| 200-Day Moving Average | $10.52 |
| FINANCIAL DATA | |
| Revenue per Share | $0.697 |
| Revenue | $169,517,000 |
| Profit Margin | -182.3% |
| Return on Equity | -0.445% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
PACB Compare Returns with S&P 500
PACB Trendline Chart